Sanofi and Boehringer Ingelheim confirmed closing (in most markets) on 1 January 2017 of a $25bn transaction involving the exchange of Sanofi’s animal health business and Boehringer Ingelheim’s consumer healthcare business.
Bär & Karrer acted as Swiss legal adviser to Sanofi. The team included Ralph Malacrida, Micha Schilling (both M&A), Mani Reinert (competition), Markus Wang and Raffael Nusser (both IP).
Weil Gotshal & Manges acted as global lead counsel to Sanofi.
#1 Lawyers Search Engine